288 related articles for article (PubMed ID: 12426685)
1. Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario AD; Smith AA; Odom LF
Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
[No Abstract] [Full Text] [Related]
2. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
3. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
4. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia.
Brigo F; Balter R; Marradi P; Ferlisi M; Zaccaron A; Fiaschi A; Frasson E; Bertolasi L
J Child Neurol; 2012 Jul; 27(7):867-74. PubMed ID: 22241706
[TBL] [Abstract][Full Text] [Related]
5. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
Neumann Y; Toren A; Rechavi G; Seifried B; Shoham NG; Mandel M; Kenet G; Sharon N; Sadeh M; Navon R
Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
[TBL] [Abstract][Full Text] [Related]
6. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
7. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
8. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
Moudgil SS; Riggs JE
Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
[TBL] [Abstract][Full Text] [Related]
9. Vindesine-induced neuropathy mimicking Guillain-Barré syndrome.
Liu L; Shi B; Ye L; Jin J; Zhang Y; Hu W; Liu M; Li G
Leuk Res; 2009 Dec; 33(12):e232-3. PubMed ID: 19428104
[TBL] [Abstract][Full Text] [Related]
10. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
[TBL] [Abstract][Full Text] [Related]
11. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
Schiavetti A; Frascarelli M; Uccini S; Novelli A
Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
[TBL] [Abstract][Full Text] [Related]
12. Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome?
Bahl A; Chakrabarty B; Gulati S; Raju KN; Raja A; Bakhshi S
Pediatr Blood Cancer; 2010 Dec; 55(6):1234-5. PubMed ID: 20544812
[TBL] [Abstract][Full Text] [Related]
13. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
14. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
15. Spinal MRI of vincristine neuropathy mimicking Guillain-Barré syndrome.
Chang YW; Yoon HK; Cho JM; Sung KW
Pediatr Radiol; 2003 Nov; 33(11):791-3. PubMed ID: 13680017
[TBL] [Abstract][Full Text] [Related]
16. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".
Walter AW
J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422
[No Abstract] [Full Text] [Related]
17. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
Olek MJ; Bordeaux B; Leshner RT
J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
[TBL] [Abstract][Full Text] [Related]
18. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I.
McGuire SA; Gospe SM; Dahl G
Med Pediatr Oncol; 1989; 17(6):520-3. PubMed ID: 2685529
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
20. Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
González Pérez P; Serrano-Pozo A; Franco-Macías E; Montes-Latorre E; Gómez-Aranda F; Campos T
Eur J Neurol; 2007 Jul; 14(7):826-8. PubMed ID: 17594344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
